Survey Shows Low Awareness and Purchase Intent on HTG Molecular Diagnostics (HTGM); Leerink Partners Cuts Price Target to $10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
HTG Molecular Diagnostics (HTGM) Tops Q3 EPS by 9c
November 12, 2015 4:42 PM ESTHTG Molecular Diagnostics (NASDAQ: HTGM) reported Q3 EPS of ($0.76), $0.09 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.07 million.
For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.
... MoreTrading Radar for 11/12: Cisco (CSCO), Viacom (VIAB), Himax (HIMX), Planet Fitness (PLNT), Fossil (FOSL) Report
November 11, 2015 3:47 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
500.com Ltd. (NYSE: WBAI) - consensus loss $0.07
AdCare Health Systems (NYSE: ADK) - no Street consensus
Advance Auto Parts (NYSE: AAP) - consensus EPS $2.09
Air Industries Group (NYSE: AIRI) - consensus EPS $0.09
Aldeyra Therapeutics (Nasdaq:... More
